Organon Valuation
| OGN Stock | USD 15.62 0.31 2.02% |
At this time, the company appears to be undervalued. Organon holds a recent Real Value of $18.8 per share. The prevailing price of the company is $15.62. Our model determines the value of Organon from analyzing the company fundamentals such as Return On Equity of 0.43, operating margin of 0.19 %, and Shares Outstanding of 257.95 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Organon's valuation include:
Undervalued
Today
Please note that Organon's price fluctuation is not too volatile at this time. Calculation of the real value of Organon is based on 3 months time horizon. Increasing Organon's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Organon is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Organon Stock. However, Organon's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 15.62 | Real 18.8 | Target 22.25 | Hype 15.49 |
The intrinsic value of Organon's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Organon's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Organon Co helps investors to forecast how Organon stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Organon more accurately as focusing exclusively on Organon's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Organon's intrinsic value based on its ongoing forecasts of Organon's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Organon's closest peers.
Organon Cash |
|
Organon Valuation Trend
Knowing Organon's actual value is paramount for traders when making sound investment determinations. Using both Organon's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Organon Total Value Analysis
Organon Co is now forecasted to have company total value of 12.15 B with market capitalization of 3.95 B, debt of 8.88 B, and cash on hands of 706 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Organon fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
12.15 B | 3.95 B | 8.88 B | 706 M |
Organon Investor Information
About 84.0% of the company shares are owned by institutional investors. The company last dividend was issued on the 24th of February 2025. Based on the analysis of Organon's profitability, liquidity, and operating efficiency, Organon Co is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.33 | 0.2321 |
|
| |||||
| Total Cash From Operating Activities | 1.7 B | 939 M |
|
| |||||
| Operating Income | 1.8 B | 1.5 B |
|
|
Organon Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Organon has an asset utilization ratio of 48.87 percent. This suggests that the Company is making $0.49 for each dollar of assets. An increasing asset utilization means that Organon Co is more efficient with each dollar of assets it utilizes for everyday operations.Organon Ownership Allocation
Organon owns a total of 257.95 Million outstanding shares. The majority of Organon Co outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Organon to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Organon. Please pay attention to any change in the institutional holdings of Organon as this could imply that something significant has changed or is about to change at the company. Please note that on June 15, 2021, Representative Scott Franklin of US Congress acquired under $15k worth of Organon's common stock.Organon Profitability Analysis
The company reported the last year's revenue of 6.4 B. Total Income to common stockholders was 864 M with profit before taxes, overhead, and interest of 3.72 B.Organon Past Distributions to stockholders
About Organon Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Organon Co. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Organon based exclusively on its fundamental and basic technical indicators. By analyzing Organon's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Organon's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Organon. We calculate exposure to Organon's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Organon's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 3.7 B | 3.6 B | |
| Pretax Profit Margin | 0.13 | 0.12 | |
| Operating Profit Margin | 0.23 | 0.33 | |
| Net Profit Margin | 0.13 | 0.24 | |
| Gross Profit Margin | 0.58 | 0.48 |
A single share of Organon represents a small ownership stake in the entity. As a stockholder of Organon, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Organon Dividends Analysis For Valuation
As of the 18th of March 2025, Dividends Paid is likely to drop to about 229.6 M. In addition to that, Dividend Yield is likely to drop to 0.04. At this time, Organon's Retained Earnings are very stable compared to the past year. As of the 18th of March 2025, Earnings Yield is likely to grow to 0.26, while Retained Earnings Total Equity is likely to drop (943.1 M).
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 297 M | 229.6 M | |
| Dividend Yield | 0.08 | 0.04 | |
| Dividend Payout Ratio | 0.34 | 0.21 | |
| Dividend Paid And Capex Coverage Ratio | 1.99 | 1.89 |
There are various types of dividends Organon can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Organon shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Organon Co directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Organon pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Organon by the value of the dividends paid out.
Organon Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 259.2 M | |
| Quarterly Earnings Growth Y O Y | -0.807 | |
| Forward Price Earnings | 5.0302 |
Organon Current Valuation Indicators
Organon's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Organon's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Organon, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Organon's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Organon's worth.When determining whether Organon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organon Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organon Co Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.81) | Dividend Share 1.12 | Earnings Share 3.33 | Revenue Per Share | Quarterly Revenue Growth (0) |
The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.